Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Covington
Chubb
Harvard Business School
Healthtrust
Moodys
Federal Trade Commission
Queensland Health
Argus Health
Julphar

Generated: August 21, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 201850

« Back to Dashboard
NDA 201850 describes SODIUM CHLORIDE 0.9%, which is a drug marketed by Medefil Inc, West-ward Pharms Int, B Braun, Baxter Hlthcare, Miles, Hospira, Taro, Fresenius Kabi Usa, Icu Medical Inc, Haemonetics, Abbott, Jubilant Hollistrstr, Laboratorios Grifols, Liebel-flarsheim, and Fresenius Medcl, and is included in twenty-nine NDAs. It is available from three suppliers. Additional details are available on the SODIUM CHLORIDE 0.9% profile page.

The generic ingredient in SODIUM CHLORIDE 0.9% is potassium chloride; sodium chloride. There are two hundred and twenty-eight drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the potassium chloride; sodium chloride profile page.

Summary for NDA: 201850

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Therapeutic Nutrients/Minerals/Electrolytes
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 201850

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SODIUM CHLORIDE 0.9%
sodium chloride
INJECTABLE;INJECTION 201850 ANDA West-ward Pharmaceutical Corp. 0641-1512 0641-1512-36 100 AMPULE in 1 CARTON (0641-1512-36) > 10 mL in 1 AMPULE (0641-1512-10)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength9MG/ML
Approval Date:Jan 20, 2012TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Citi
UBS
Express Scripts
Boehringer Ingelheim
Federal Trade Commission
Chinese Patent Office
Covington
Johnson and Johnson
Novartis
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot